SIRT7 and lung carcinoma: SIRT7 promotes proliferation and migration of lung cancer cells both in vitro and in vivo by stimulating G1/S cell cycle transition and promoting EMT mainly through activation of the AKT and ERK1/2 signaling cascades (Figs. 5A, B and Table 1) [73].